Advice
Following an abbreviated submission.
Triptorelin 11.25mg injection every 3 months (Decapeptyl SR) is accepted for use within NHS Scotland for the treatment of endometriosis in patients for whom the use of triptorelin is appropriate and who would benefit from reduced frequency of administration compared with triptorelin 3mg injection every 4 weeks (Decapeptyl).
Download detailed advice29KB (PDF)
Medicine details
- Medicine name:
- Triptorelin 11.25mg injection (Decapeptyl SR®)
- SMC ID:
- 207/05
- Indication:
- Endometriosis
- Pharmaceutical company
- Ipsen Ltd
- BNF chapter
- Endocrine system
- Submission type
- Abbreviated
- Status
- Accepted
- Date advice published
- 10 October 2005